Published date: 19/09/2025

Our new recombinant Glucose Dehydrogenase enzyme

Advancing diabetes care, together

Our new recombinant Glucose Dehydrogenase enzyme

We’re excited to introduce a recombinant FAD-dependent Glucose Dehydrogenase (FAD-GDH) designed for use in continuous glucose monitoring devices – supporting more accurate and reliable diabetes management.

Manufactured in the UK as a primary manufacturer

Scalable to bulk quantities to meet global demand

Verified in-application performance

Samples now available

By combining scientific precision with scalable supply, we’re helping manufacturers bring better solutions to people living with diabetes.

Contact us to request samples.

Contact Us

SIGN-UP

Keep in touch

Put performance data, early reagent releases, and news & offers in your inbox. Join us in advancing health, together.

This field is for validation purposes and should be left unchanged.